These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 382892)

  • 1. [Reaction of the ovaries to endogenous gonadotropins in women after single administration of releasing hormone stimulating the secretion of luteinizing hormone].
    Potin VV; Svechnikova FA; Khrustaleva GF; Chembartseva AV
    Akush Ginekol (Mosk); 1979 May; (5):13-5. PubMed ID: 382892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indices of the functional state of the hypothalamus-hypophysis-ovaries system in women with Itsenko-Cushing disease].
    Manusharova RA
    Vrach Delo; 1990 Apr; (4):74-7. PubMed ID: 2275178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
    N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of hormones in amenorrhea].
    Belaïsch J
    Concours Med; 1976 Nov; 98(40 Pt 2):6057-8, 6061-78. PubMed ID: 791570
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reevaluation of "hypothalamic" amenorrhea and its diagnosis and therapy].
    Yaginuma T; Nishii O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1777-80. PubMed ID: 3148674
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of single injections and continuous i.v. infusions of synthetic gonadotropin releasing hormone in normal women and patients with primary and secondary amenorrhea.
    Jewelewicz R; Dyrenfurth I; Warren M; Ferin M; Ans R; Khalaf S; Vande Wiele R
    Eur J Obstet Gynecol Reprod Biol; 1974; 4(1 SUPPL):S175-85. PubMed ID: 4606496
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian response to luteinizing hormone-releasing hormone (LH-RH) in normal women and amenorrheic patients.
    Figueroa-Casas PR; de Laborde NP; Badano A; Pedroza García E; Aparicio N; Miechi H; Mirkin A; Arcangeli O; Rosner JM
    Reproduccion; 1975; 2(1):1-6. PubMed ID: 1102368
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation principles of female gonadal function. Experimental observations and clinical significance].
    Czygan PJ
    Fortschr Geburtshilfe Gynakol; 1974; 52():121-98. PubMed ID: 4618236
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian stimulation test using human menopausal gonadotrophin (HMG).
    Netter A; Millet D; Salomon-Bernard Y
    J Reprod Fertil; 1970 Mar; 21(2):313-7. PubMed ID: 5443212
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonadotropin response to luteinizing hormone releasing hormone administration in secondary amenorrhea and galactorrhea syndromes.
    Wentz AC; Jones GS; Rocco L; Matthews RR
    Obstet Gynecol; 1975 Mar; 45(3):256-62. PubMed ID: 1089929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic use of luteinizing hormone releasing hormone in primary amenorrhea.
    Wentz AC; Jones GS; Barnes HV
    Obstet Gynecol; 1975 Mar; 45(3):247-55. PubMed ID: 1089928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump ("Zyklomat")--a new approach to the treatment of infertility in hypothalamic amenorrhea.
    Leyendecker G; Wildt L; Hansmann M
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1214-6. PubMed ID: 6775002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited significance of the LRH test in the diagnosis of ovarian dysfunction.
    Böhm P; Fenske M; Häffele R; König A
    Acta Endocrinol (Copenh); 1978 Nov; 89(3):438-44. PubMed ID: 360751
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of luliberin and chorionic gonadotropin on luteinizing hormone and testosterone levels in the blood of monkeys under acute stress].
    Katsiia GV; Chirkov AM; Goncharov NP
    Probl Endokrinol (Mosk); 1984; 30(1):73-7. PubMed ID: 6369303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.